SPDR S&P Pharmaceuticals ETF
XPH
XPH
71 hedge funds and large institutions have $105M invested in SPDR S&P Pharmaceuticals ETF in 2024 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 22 reducing their positions, and 10 closing their positions.
Holders
71
Holders Change
-2
Holders Change %
-2.74%
% of All Funds
1.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
19
Reduced
22
Closed
10
Calls
$839K
Puts
$1.51M
Net Calls
-$669K
Net Calls Change
-$246K
Top Buyers
| 1 |
EH
1
Equitable Holdings
New York
|
$10.4M |
| 2 |
2
Jane Street
New York
|
$2.31M |
| 3 |
RW
3
Rockport Wealth
Fairview Park,
Ohio
|
$1.81M |
| 4 |
4
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$1.51M |
| 5 |
5
Two Sigma Investments
New York
|
$286K |
